Anabel Costa-Ferreira

1 week ago | insights.citeline.com | Anabel Costa-Ferreira

Global Guideline Signals ‘Paradigm Shift’ For Pregnant And Breastfeeding Women, Says EMAThe European Medicines Agency expects the International Council for Harmonization’s new guideline will help address the critical lack of data on the use of medicinal products in pregnant and breastfeeding populations. (Shutterstock/AI-generated)

1 week ago | insights.citeline.com | Anabel Costa-Ferreira

Podcast: Brain+ CEO Discusses “Groundbreaking” Potential Of CST Assistant For Dementia Patients Devika Wood, CEO of Brain+, explains the importance of developing health tech solutions for dementia and the growing need to both raise awareness and improve overall access to nondrug interventions like CST.

2 weeks ago | insights.citeline.com | Vibha Sharma |Anabel Costa-Ferreira

Global Pharma Guidance Tracker - May 2025Stay up to date on regulatory guidelines from around the world with the Pink Sheet’s Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.

2 weeks ago | insights.citeline.com | Anabel Costa-Ferreira

Rising Leaders 2025: Emma Hodcroft On Taking Initiative When “Plan A” Falls Short Emma Hodcroft, co-founder of Pathoplexus and a key Nextstrain contributor, stresses the importance of career flexibility for young scientists. She urges early-stage researchers to embrace curiosity, using her unconventional path as an example of how curiosity can lead to impactful success.

3 weeks ago | insights.citeline.com | Anabel Costa-Ferreira

Infographic: Leqembi – A Geographical ComparisonThe Pink Sheet explores how regulatory approvals for Leqembi differ around the world, and looks at what is coming next. Eisai and Biogen's follow-up Alzheimer's treatment has met with varying success around the globe. (Shutterstock/AI-generated)